57
Participants
Start Date
August 31, 2005
Primary Completion Date
February 28, 2010
Study Completion Date
May 31, 2010
C1 Esterase Inhibitor
Lyophilisate containing approximately 500 U C1-INH to be reconstituted with 10 mL water for injection; Single Dose: 20 U/kg b.w. iv
Contact CSL Behring for facility details, Hershey
Contact CSL Behring for facility details, Atlanta
Contact CSL Behring for facility details, Weston
Contact CSL Behring for facility details, Plymouth
Contact CSL Behring for facility details, Rapid City
Contact CSL Behring for facility details, Omaha
Contact CSL Behring for facility details, Shreveport
Contact CSL Behring for facility details, Tulsa
Contact CSL Behring for facility details, Dallas
Contact CSL Behring for facility details, Idaho Falls
Contact CSL Behring for facility details, Eugene
Contact CSL Behring for facility details, Chicago
Contact CSL Behring for facility details, Boston
Contact CSL Behring for facility details, Ottawa
Lead Sponsor
CSL Behring
INDUSTRY